Successfully Closes $12M Public Offering, Strengthens Balance Sheet and Supports Anticipated U.S. Launch- Recent Peer-Reviewed Publication Demonstrates Advantages of Hybrid IVUS-OCT Imaging TORONTO, ...

New Academic Data Supports Clinical and Commercial Value of Hybrid Imaging Platform-TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”), a leader in hybrid ...

Despite substantial advances in guideline-directed medical therapy, recurrent hospitalization remains a persistent challenge in the management of congestive heart failure (CHF). Fluid overload is ...

Final follow-up from the trial shows durable protection against TLF, especially in chronic total occlusions and diffuse long ...

Precision Bb Targeting, Robust Efficacy, Transfusion Independence, Excellent Safety in Phase II PNH Study, and Subcutaneous Administration The 12-16-week open-label study evaluated Ruxoprubart as ...

Precision angioplasty also improves the accuracy of choosing the right stent size and length. Because the vessel measurements ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Spryte Medical announced the commencement of enrollment in the INSYTE trial evaluating the company’s neuro-optical CT (nOCT) ...

Initial enrollments were completed with the neurointerventional team at Baptist Health Jacksonville, led by Ricardo Hanel, MD, PhD, neurosurgeon, who serves as Co-Principal Investigator of the INSYTE ...

The human body is home to many types of fungi. Some are beneficial and others are deadly, but that distinction can often change depending on where the particular fungus resides. While the fungi ...

Introduction Carotid artery stenosis (CAS) is a major cause of stroke, disability, and mortality worldwide. While medical therapy and revascularization remain the cornerstones of management, both ...

Edwards Lifesciences (NYSE: EW) and Boston Scientific (NYSE: BSX) both reported strong quarters, but the results reveal fundamentally different strategies in the heart device market. Edwards doubled ...